FICO — Fair Isaac Corporation

Market sentiment is risk-off after the dated September 2026 FHFA regulatory shock, with the stock down 18.4% in one week and 36.2% over six months as of 2026-09-04. Sell-side ratings remain buy-heavy (16 Buy / 4 Hold) and the consensus target is still ~$1,539, but recent UBS, Wolfe, Barclays, and RBC revisions show analysts trimming targets and becoming more nervous about FICO Score's competitive position in mortgages.

Reported revenue growth has inflected sharply higher in FY2026, but unevenly: YoY growth by fiscal quarter was roughly +13.7% in Sep-2025, +16.4% in Dec-2025, +38.7% in Mar-2026, and +25.7% in Jun-2026. The March-2026 revenue spike to $691.7M is lumpy and should not be extrapolated; the normalized trend is better described as mid-teens to mid-20s growth. Operating margin expanded from roughly 48.9% in Jun-2025 to 53.8% in Jun-2026, and EPS grew faster than revenue, aided by share buybacks and the negative-equity capital structure. Cash-flow quality is solid: TTM operating cash flow of ~$1.00B exceeds TTM net income of ~$0.82B, so the accrual red flag is not present.

As of 2026-09-04, FICO is cheap versus its own history: TTM P/E is 27.1x versus the 5-year average of 51.5x, P/S is 8.5x versus 15.4x, and PEG is roughly 0.80. Using the consensus next-FY EPS estimate of $42.94, the forward P/E is about 22x. That is a substantial valuation cushion if VantageScore fears are overdone, but it also tells you the market is already applying a structural discount for regulatory and competitive risk; on a pure forward P/E basis it is fair-to-cheap, not statistically cheap in absolute terms.

At $943.26, the market is no longer paying a premium for FICO's historical growth; it is pricing roughly 22x consensus forward EPS. If EPS holds near $43 and the multiple merely normalizes toward the low end of its historical range (~27x), fair value would be around $1,160. If regulatory pressure cuts earnings power to ~$35, a 27x multiple still supports roughly $945, meaning the current price embeds an adverse scenario. The real bear case requires both lower earnings and a lower multiple, and that is why the stock is interesting but not a low-risk setup.

As of 2026-09-04, the technical picture is oversold but firmly in a downtrend: RSI is 30.77, price is -14.9% below the 20-day SMA, -19.4% below the 50-day SMA, and -27.9% below the 200-day SMA. One-week return is -18.4%, three-month -17.3%, and six-month -36.2%. This is a falling-knife posture; oversold bounces are possible, but there is no confirmed reversal signal yet. Long-term buyers may begin scaling in near the low-$900s, but a prudent entry trigger would be stabilization above the 20-day SMA or a successful retest of the $870-$920 area.

• FHFA directive in September 2026 ordering Fannie Mae and Freddie Mac to approve VantageScore 4.0 for all mortgage lenders, directly challenging FICO Score's mortgage monopoly.
• High mortgage rates and weak housing affordability continue to compress mortgage origination volumes, pressuring transaction-based scoring revenue.
• Broader political/regulatory scrutiny of credit-score pricing and so-called credit bureau cartels could limit future price increases or force new scoring structures.
• Persistent elevated rates and a slowing consumer credit cycle may reduce credit card, auto, and personal-loan inquiry volumes.
• FICO's software transition is creating lumpy reported revenue: platform recurring revenue is growing fast, while legacy non-platform revenue is declining sharply.

• Q4 and full-year FY2026 earnings, expected late October/early November 2026, which should clarify whether FHFA-related volume shifts are actually showing up and provide FY2027 guidance.
• FHFA/GSE implementation updates — if mortgage lenders slow-walk VantageScore adoption or if FICO remains the default primary score, the regulatory overhang could lift materially.
• Analyst estimate and target stabilization after post-event revisions from UBS, RBC, Barclays, and Wolfe, which could help the stock form a technical bottom.
• Capital allocation updates: FICO issued a $1.5B term loan and executed a $1.5B ASR, so debt paydown and future buyback plans are meaningful catalysts for EPS.

• VantageScore becomes an equal-cost option in GSE mortgages and lenders rapidly substitute away from FICO, causing a structural decline in FICO Score volumes and pricing power.
• Regulatory pressure broadens beyond mortgages, threatening FICO's economics in credit cards, auto lending, and other consumer credit vertically.
• Leverage is elevated after the ASR: long-term debt rose to ~$5.28B and stockholders' equity is -$4.10B, leaving less flexibility if earnings weaken.
• Recent revenue growth may be inflated by lumpy software/timing; a more normal Q4 could cause the momentum narrative to cool.
• A broader macroeconomic downturn would reduce consumer credit and mortgage activity, compounding the regulatory and competitive pressures.

FICO is one of the highest-quality analytics franchises in the market — ~85% gross margin, ~54% latest operating margin, 53% ROIC, and TTM FCF near $1B. At $943.26, the stock is paying ~22x forward EPS, which builds in meaningful damage from the FHFA/VantageScore threat. For a 3-5 year horizon, I lean cautiously bullish because the valuation cushion and franchise quality likely outweigh the real, dated regulatory risk, but this is not a stock to chase before the technical and regulatory picture stabilizes.

Theoretical fair value is calculated by applying a 28.0x forward P/E to the consensus next-FY EPS estimate of $42.94. I chose 28x as a deliberate discount to FICO's 5-year average P/E of 51.5x to reflect regulatory/VantageScore risk and higher rates, while still allowing a premium for FICO's 85% gross margin, ~52-54% operating margin, 53% ROIC, and likely double-digit EPS growth; 42.94 × 28.0 ≈ $1,202.26.